Tricuspid Regurgitation
Evaluate TR severity and explore intervention pathways. TR is frequently encountered in perioperative echocardiography — its clinical impact depends on mechanism, right-heart adaptation, and context.
Assess TR severity
Grade TR severity using ACC/AHA 2020 integrated criteria: qualitative grade, vena contracta width, PISA EROA, regurgitant volume, hepatic vein systolic flow, and CW Doppler contour.
TR Intervention Navigator
See the evaluation pathway once severe TR and its mechanism are confirmed — including device lead-associated and atrial functional TR, right-heart function, and clinical context.
Learn TR
- TR severity criteria at a glanceArticle
- Why TR Vmax does not equal TR severityArticle
- Why hepatic vein systolic reversal mattersArticle
- TR mechanism determines the management pathwayArticle
- Device lead-associated TR: why the team mattersArticle
- Why severe TR should not wait for RV and end-organ damageArticle
- Left-sided valve surgery and TR: evaluate explicitly, do not repair automaticallyArticle
- Severe TR before noncardiac surgery: risk framing, not a one-click answerArticle
TR cases
Clinical context
Mechanism drives management
Primary structural, secondary ventricular functional, atrial functional, and device lead-associated TR follow different pathways. Device lead TR is a mechanical lead-valve problem, not a form of secondary TR — although functional TR can coexist. Confirm severity and mechanism before applying intervention criteria.
Right-heart adaptation matters
TR severity alone does not determine urgency. RV size, function, TAPSE, IVC plethora, and congestion signs contextualize the hemodynamic burden and guide clinical decisions.
TR Vmax is not a severity signal
TR Vmax reflects the RV-RA pressure gradient and is used for PASP estimation. In severe TR, pressure equalization reduces the gradient — low TR Vmax does not exclude severe TR, and high TR Vmax does not confirm it.